Dr. Reddy's Powers Ahead: G V Prasad Reappointed, Dividend Announced, and Q4 Beats Estimates

Dr. Reddy's Laboratories has posted a stellar Q4 FY25 set of results, highlighting its resilience and growth in the global pharma space. The board of the company has reappointed G V Prasad as Co-Chairman and Managing Director, guaranteeing leadership continuity at a critical juncture. Prasad's strategic vision has been the key to Dr. Reddy's global expansion and innovation-led growth.

 

Key Highlights:

With good leadership, shareholder-friendly dividend, and sound financials, Dr. Reddy's is set to grow and create value in the future.

 

Sources: Moneycontrol, Goodreturns, Investing.com